表紙
市場調査レポート

動物・家畜用ワクチンの世界市場の予測 〜2021年:狂犬病・FMD・豚インフルエンザ・腺疫・フルンケル症

Veterinary/Animal Vaccines Market Product (Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture), Diseases (Rabies, FMD, Swine Influenza, Strangles, Furunculous), Technology (DNA, Recombinant, Inactivated, Conjugate) - Forecast to 2021

発行 MarketsandMarkets 商品コード 281737
出版日 ページ情報 英文 190 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
動物・家畜用ワクチンの世界市場の予測 〜2021年:狂犬病・FMD・豚インフルエンザ・腺疫・フルンケル症 Veterinary/Animal Vaccines Market Product (Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture), Diseases (Rabies, FMD, Swine Influenza, Strangles, Furunculous), Technology (DNA, Recombinant, Inactivated, Conjugate) - Forecast to 2021
出版日: 2016年08月11日 ページ情報: 英文 190 Pages
概要

世界の動物・家畜用ワクチンの市場は2016年から2021年にかけて5.8%のCAGR (年間複合成長率) で推移し、2016年の58億1000万米ドルから、2021年には76億8000万米ドルの規模に成長する見通しです。家畜数の増加や家畜疾患の度重なる発生、人畜共通疾患の増加、各種政府機関、動物関連団体、主要事業者などによるイニシアチブの整備、新たなタイプのワクチンの導入などの要因が同市場の成長を推進しています。

当レポートでは、世界の動物・家畜用ワクチンの市場を調査し、市場および製品の概要、市場成長への各種影響因子と市場機会の分析、製品/対象動物・疾患区分・ワクチン技術・地域など各種区分別の動向と市場規模の推移と予測、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

  • イントロダクション
  • 現在のシナリオ
  • 将来の展望
  • 総論

第4章 重要考察

  • 安定的市場成長の見通し
  • 製品別市場
  • 地域別市場
  • ライフサイクル分析:地域別

第5章 動物・家畜用ワクチンの世界市場:概要

  • イントロダクション
  • 市場ダイナミクス
    • 推進要因
    • 抑制要因
    • 機会
    • 課題

第6章 動物・家畜用ワクチンの世界市場:製品別

  • イントロダクション
    • ブタ用ワクチン
    • 鶏用ワクチン
    • 家畜用ワクチン
    • ペット用ワクチン
    • ウマ用ワクチン
    • 水産養殖用ワクチン
    • その他

第7章 動物・家畜用ワクチンの世界市場:疾病別

  • イントロダクション
  • ブタ用ワクチン
  • 鶏用ワクチン
  • 家畜用ワクチン
    • 小型反芻動物
  • ペット用ワクチン
  • ウマ用ワクチン
  • 水産養殖用ワクチン

第8章 動物・家畜用ワクチンの世界市場:技術別

  • イントロダクション
  • 弱毒化生ワクチン (LAV)
  • 不活化ワクチン
  • トキソイドワクチン
  • 組み換えワクチン
  • 結合型ワクチン
  • サブユニットワクチン
  • DNAワクチン

第9章 動物・家畜用ワクチンの世界市場:地域別

  • イントロダクション
  • 欧州
  • 北米
  • アジア
    • 中国
    • タイ
    • インド
    • 韓国
  • その他
    • ブラジル

第10章 競合環境

  • 概要
  • 戦略分析
  • 市場シェア分析
  • 主な発展動向:製品別
  • 競合状況・動向

第11章 企業プロファイル

  • イントロダクション
  • ZOETIS
  • MERCK ANIMAL HEALTH
  • MERIAL INC. (SANOFI)
  • BOEHRINGER INGELHEIM
  • ELANCO ANIMAL HEALTH (ELI LILLY)
  • BAYER HEALTHCARE
  • CEVA ANIMAL HEALTH
  • HESKA CORPORATION
  • VETOQUINOL
  • VIRBAC LTD.

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PH 3475

"Increase In Livestock Population And Repeated Breakouts Of Livestock Diseases, Increasing Incidence Of Zoonotic Diseases, Initiatives By Various Government Agencies, Animal Associations, And Leading Players, And The Introduction Of New Vaccine Types To Drive the Growth of Veterinary Vaccine Market"

In this market, primary investment opportunities are in emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India; these are lucrative markets for veterinary vaccines, owing to favorable government initiatives.

The global veterinary vaccines market is poised to reach USD 7.68 billion by 2021 from USD 5.81 billion in 2016, at a CAGR of 5.8% from 2016 to 2021.

The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and region. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. In this market, companion animal vaccines form the fastest-growing product segment, due to the increasing number of zoonotic diseases in the human population and the growing number of pet owners worldwide.

The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to account for the highest growth of the veterinary vaccines market in 2016, due to innovations in technology and increased public awareness about animal vaccination.

New and innovative product launches and collaboration were the dominant strategies adopted by companies in this market.

This research report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and government initiatives. The competitive landscape covers growth strategies adopted by industry players in the last three years. Company profiles comprise basic views on key players in the veterinary vaccines market and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis (industry trends) and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the veterinary vaccines market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products offered by top players in the veterinary vaccines market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the veterinary vaccines market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for veterinary vaccines across various regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the veterinary vaccines market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and the manufacturing capabilities of leading players in the veterinary vaccines market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key industry insights
  • 2.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. VETERINARY VACCINES MARKET (2016-2021) TO GROW AT A STEADY RATE
  • 4.2. VETERINARY VACCINES MARKET, BY PRODUCT
  • 4.3. VETERINARY VACCINES MARKET, BY REGION
  • 4.4. LIFECYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increase in livestock population and repeated breakouts of livestock diseases
      • 5.2.1.2. Rise in incidences of zoonotic diseases
      • 5.2.1.3. Initiatives by various government agencies, animal associations, and leading players
      • 5.2.1.4. Introduction of new types of vaccines
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Rising costs for the storage of vaccines
      • 5.2.2.2. Increasing prices of meat promoting the adoption of vegetarian diets
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Technological innovation
      • 5.2.3.2. Growing awareness of animal health in emerging economies
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Inadequate surveillance and reporting systems

6. VETERINARY VACCINES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
    • 6.1.1. PORCINE VACCINES
    • 6.1.2. POULTRY VACCINES
    • 6.1.3. LIVESTOCK VACCINES
    • 6.1.4. COMPANION ANIMAL VACCINES
    • 6.1.5. EQUINE VACCINES
    • 6.1.6. AQUACULTURE VACCINES
    • 6.1.7. OTHER ANIMAL VACCINES

7. VETERINARY VACCINES MARKET, BY DISEASE

  • 7.1. INTRODUCTION
  • 7.2. PORCINE VACCINES
  • 7.3. POULTRY VACCINES
  • 7.4. LIVESTOCK VACCINES
    • 7.4.1. BOVINE VACCINES
    • 7.4.2. SMALL RUMINANT VACCINES
  • 7.5. COMPANION ANIMAL VACCINES
    • 7.5.1. CANINE VACCINES
    • 7.5.2. FELINE VACCINES
  • 7.6. EQUINE VACCINES
  • 7.7. AQUACULTURE VACCINES

8. VETERINARY VACCINES MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. LIVE ATTENUATED VACCINES
  • 8.3. INACTIVATED VACCINES
  • 8.4. TOXOID VACCINES
  • 8.5. RECOMBINANT VACCINES
  • 8.6. CONJUGATE VACCINES
  • 8.7. SUBUNIT VACCINES
  • 8.8. DNA VACCINES

9. VETERINARY VACCINES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. EUROPE
  • 9.3. NORTH AMERICA
  • 9.4. ASIA
    • 9.4.1. CHINA
    • 9.4.2. THAILAND
      • 9.4.2.1. Regulatory landscape for veterinary vaccines in Thailand
    • 9.4.3. INDIA
    • 9.4.4. SOUTH KOREA
      • 9.4.4.1. Regulatory scenario
        • 9.4.4.1.1. Regulatory authorities: veterinary health and safety
      • 9.4.4.2. Related regulations
      • 9.4.4.3. Regulatory requirements
      • 9.4.4.4. Quality and safety control system
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. BRAZIL

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. STRATEGIC ANALYSIS
  • 10.3. MARKET SHARE ANALYSIS
  • 10.4. VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS, BY PRODUCT (2013-2015)
    • 10.4.1. RECENT NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS BY MARKET PLAYER (2013-2016)
      • 10.4.1.1. Zoetis (PFIZER)
      • 10.4.1.2. Merck animal health
      • 10.4.1.3. Boehringer Ingelheim Inc.
      • 10.4.1.4. Ceva animal health
  • 10.5. COMPETITIVE SITUATION AND TRENDS
    • 10.5.1. NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS
    • 10.5.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.5.3. ACQUISITIONS
    • 10.5.4. EXPANSIONS
    • 10.5.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*

  • 11.1. INTRODUCTION
  • 11.2. ZOETIS
  • 11.3. MERCK ANIMAL HEALTH
  • 11.4. MERIAL INC. (SANOFI)
  • 11.5. BOEHRINGER INGELHEIM
  • 11.6. ELANCO ANIMAL HEALTH (ELI LILLY)
  • 11.7. BAYER HEALTHCARE
  • 11.8. CEVA ANIMAL HEALTH
  • 11.9. HESKA CORPORATION
  • 11.10. VETOQUINOL
  • 11.11. VIRBAC LTD.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER COMPANY DEVELOPMENTS (2013-2016)
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.6. AVAILABLE CUSTOMIZATIONS
  • 12.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: REPORTED ZOONOSES (2012-1016)
  • TABLE 2: GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE THE VETERINARY VACCINES MARKET
  • TABLE 3: HIGH STORAGE COST OF VACCINES TO RESTRAIN MARKET GROWTH
  • TABLE 4: TECHNOLOGICAL ADVANCEMENTS, A KEY AREA OF OPPORTUNITY IN THE MARKET
  • TABLE 5: INADEQUATE SURVEILLANCE AND REPORTING SYSTEMS IS A MAJOR CHALLENGE IN THE MARKET
  • TABLE 6: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 7: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 8: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 9: LIVESTOCK VACCINES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 10: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 11: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 12: COMPANION ANIMAL VACCINES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 13: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 14: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 15: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 16: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 17: VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 18: LIVE ATTENUATED VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: INACTIVATED VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014-2021 (USD MILLION)
  • TABLE 20: TOXOID VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014-2021 (USD MILLION)
  • TABLE 21: RECOMBINANT VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014-2021 (USD MILLION)
  • TABLE 22: CONJUGATE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014-2021 (USD MILLION)
  • TABLE 23: SUBUNIT VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014-2021 (USD MILLION)
  • TABLE 24: DNA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014-2021 (USD MILLION)
  • TABLE 25: VETERINARY VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: EUROPE: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 27: EUROPE: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 28: EUROPE: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 29: EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 30: EUROPE: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 31: EUROPE: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 32: EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 33: EUROPE: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 34: EUROPE: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 35: EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 38: EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 39: EUROPE: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 40: EUROPE: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 41: EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 55: NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 56: NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 57: NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 58: NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 59: NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 60: CHINA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: CHINA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 62: CHINA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 63: CHINA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 64: CHINA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 65: CHINA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 66: CHINA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 67: CHINA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 68: CHINA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 69: CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 70: CHINA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 71: CHINA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 72: CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 73: CHINA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 74: CHINA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 75: CHINA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 76: CHINA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 77: THAILAND: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: THAILAND: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 79: THAILAND: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 80: THAILAND: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 81: THAILAND: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 82: THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 83: THAILAND: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 84: THAILAND: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 85: THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 86: THAILAND: LIVESTOCK ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 87: THAILAND: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 88: THAILAND: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 89: THAILAND: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 90: INDIA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 91: INDIA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 92: INDIA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 93: INDIA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 94: INDIA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 95: INDIA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 96: INDIA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 97: INDIA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 98: INDIA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 99: INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 100: INDIA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 101: INDIA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 102: INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 103: INDIA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 104: INDIA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 105: INDIA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 106: INDIA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 107: SOUTH KOREA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 108: SOUTH KOREA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 109: SOUTH KOREA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 110: SOUTH KOREA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 111: SOUTH KOREA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 112: SOUTH KOREA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 113: SOUTH KOREA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 114: SOUTH KOREA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 115: SOUTH KOREA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 116: SOUTH KOREA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 117: SOUTH KOREA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 118: SOUTH KOREA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 119: SOUTH KOREA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 120: SOUTH KOREA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 121: SOUTH KOREA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 122: BRAZIL: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 123: BRAZIL: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 124: BRAZIL: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 125: BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 126: BRAZIL: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 127: BRAZIL: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 128: BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 129: BRAZIL: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 130: BRAZIL: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 131: BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014-2021 (USD MILLION)
  • TABLE 132: BRAZIL: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 133: BRAZIL: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 134: BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 135: BRAZIL: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 136: BRAZIL: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 137: BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 138: BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 139: VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013-2016)
  • TABLE 140: NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS, 2013-2016
  • TABLE 141: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 142: ACQUISITIONS, 2013-2016
  • TABLE 143: EXPANSIONS, 2013-2016
  • TABLE 144: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: VETERINARY VACCINES MARKET
  • FIGURE 2: MARKET SIZE ESTIMATION APPROACH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: DATA TRIANGULATION METHODOLOGY
  • FIGURE 5: VETERINARY VACCINES MARKET, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 6: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: PORCINE VACCINES MARKET, BY DISEASE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: CANINE VACCINES MARKET, BY DISEASE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: VETERINARY VACCINES MARKET, BY REGION, 2016 (USD MILLION)
  • FIGURE 10: ATTRACTIVE MARKET OPPORTUNITIES
  • FIGURE 11: PORCINE VACCINES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2016
  • FIGURE 12: ASIA EXPECTED TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD
  • FIGURE 13: ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 14: INCREASE IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES TO BOOST MARKET GROWTH
  • FIGURE 15: PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VETERINARY VACCINES MARKET IN 2016
  • FIGURE 16: PORCINE CIRCOVIRUS SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN PORCINE VACCINES MARKET, BY 2021
  • FIGURE 17: INFECTIOUS BRONCHITIS SEGMENT TO DOMINATE THE POULTRY VACCINES MARKET IN 2016
  • FIGURE 18: BVD SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE BOVINE VACCINES MARKET BY 2021
  • FIGURE 19: CLOSTRIDIAL DISEASES SEGMENT TO DOMINATE THE SMALL RUMINANT VACCINES MARKET IN 2016
  • FIGURE 20: CANINE DISTEMPER SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE CANINE VACCINES MARKET BY 2021
  • FIGURE 21: FELINE RABIES SEGMENT IS EXPECTED TO DOMINATE THE FELINE VACCINES MARKET IN 2016
  • FIGURE 22: EQUINE RHINOPNEUMONITIS SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE EQUINE VACCINES MARKET
  • FIGURE 23: VIBRIOSIS TO DOMINATE THE AQUACULTURE VACCINES MARKET, BY DISEASE, IN 2016
  • FIGURE 24: LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2016
  • FIGURE 25: POULTRY VACCINES SEGMENT IS EXPECTED TO DOMINATE THE LIVE ATTENUATED VACCINES MARKET IN 2016
  • FIGURE 26: COMPANION ANIMAL VACCINES SEGMENT TO REGISTER HIGHEST GROWTH RATE IN THE INACTIVATED VACCINES MARKET
  • FIGURE 27: LIVESTOCK VACCINES TO DOMINATE THE TOXOID VACCINES MARKET IN 2016
  • FIGURE 28: POULTRY VACCINES SEGMENT TO GROW AT THE HIGHEST RATE IN THE RECOMBINANT VACCINES MARKET
  • FIGURE 29: PORCINE VACCINES TO DOMINATE THE CONJUGATE VACCINES MARKET IN 2016
  • FIGURE 30: LIVESTOCK VACCINES TO GROW AT THE HIGHEST RATE IN THE SUBUNIT VACCINES MARKET FROM 2016 TO 2021
  • FIGURE 31: PORCINE VACCINES SEGMENT IS EXPECTED TO DOMINATE THE DNA VACCINES MARKET
  • FIGURE 32: GEOGRAPHIC SNAPSHOT: ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 33: ASIA, AN ATTRACTIVE REGION FOR ALL PRODUCT CATEGORIES
  • FIGURE 34: EUROPE WILL CONTINUE TO LEAD THE GLOBAL VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
  • FIGURE 35: THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY THE GROWING PRODUCTION OF PIG MEAT IN THE FORECAST PERIOD
  • FIGURE 36: THE PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN VETERINARY VACCINES MARKET IN 2016
  • FIGURE 37: RECOMBINANT VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN THE EUROPEAN VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD
  • FIGURE 38: THE INACTIVATED VACCINES TECHNOLOGY SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN COMPANION ANIMAL VACCINES MARKET
  • FIGURE 39: COMPANION ANIMAL VACCINES WILL BE THE FASTEST-GROWING SEGMENT FOR NORTH AMERICAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
  • FIGURE 40: THE LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN LIVESTOCK VACCINES MARKET
  • FIGURE 41: ASIA MARKET SNAPSHOT: THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY INCREASING INCIDENCES OF ZOONOTIC DISEASES
  • FIGURE 42: THE LIVESTOCK VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN CHINA
  • FIGURE 43: CONJUGATE VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN THE ASIAN VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD
  • FIGURE 44: STEPS INVOLVED IN THE MARKETING AUTHORIZATION APPROVAL OF VETERINARY VACCINES IN THAILAND
  • FIGURE 45: REGISTRATION PROCESS
  • FIGURE 46: THE PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE THAILAND VETERINARY VACCINES MARKET IN 2016
  • FIGURE 47: RECOMBINANT VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE VETERINARY VACCINES MARKET IN THAILAND DURING THE FORECAST PERIOD
  • FIGURE 48: LIVESTOCK VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN INDIA
  • FIGURE 49: CONJUGATE VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE INDIAN LIVESTOCK VACCINES MARKET
  • FIGURE 50: SOUTH KOREAN VETERINARY VACCINES MARKET: REGULATORY AUTHORITIES AND THEIR RESPECTIVE ROLES
  • FIGURE 51: PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN SOUTH KOREA
  • FIGURE 52: INACTIVATED VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE SOUTH KOREAN POULTRY VACCINES MARKET
  • FIGURE 53: POULTRY VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN BRAZIL
  • FIGURE 54: INACTIVATED VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE POULTRY VACCINES MARKET IN BRAZIL
  • FIGURE 55: KEY DEVELOPMENTS IN THE VETERINARY VACCINES MARKET, 2013-2016
  • FIGURE 56: GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 57: VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013-2016)
  • FIGURE 58: ZOETIS (PFIZER) FOCUSED ON PORCINE AND POULTRY SEGMENT IN THE LAST FEW YEARS (2013-2016)
  • FIGURE 59: MERCK CONCENTRATED ON THE AQUACULTURE SEGMENT (2013-2016)
  • FIGURE 60: BOEHRINGER INGELHEIM MAINLY CONCENTRATED ON EQUINE AND PORCINE SEGMENT (2013-2016)
  • FIGURE 61: CEVA RELEASED NEW PRODUCTS FOR THE POULTRY SEGMENT (2013-2016)
  • FIGURE 62: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS-THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2013 & 2016
  • FIGURE 63: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
  • FIGURE 64: ZOETIS: COMPANY SNAPSHOT
  • FIGURE 65: MERCK ANIMAL HEALTH: COMPANY SNAPSHOT
  • FIGURE 66: MERIAL INC. (SANOFI): COMPANY SNAPSHOT
  • FIGURE 67: BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
  • FIGURE 68: ELI LILLY: COMPANY SNAPSHOT
  • FIGURE 69: BAYER HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 70: CEVA ANIMAL HEALTH: COMPANY SNAPSHOT
  • FIGURE 71: HESKA CORPORATION: COMPANY SNAPSHOT
  • FIGURE 72: VETOQUINOL: COMPANY SNAPSHOT
  • FIGURE 73: VIRBAC LTD.: COMPANY SNAPSHOT
Back to Top